Literature DB >> 28745241

The Role of Innate Immune System Receptors in Epilepsy Research.

Jessica Cordero-Arreola1, Rachel M West1, Julieta Mendoza-Torreblanca2, Edna Mendez-Hernandez3, Jose Salas-Pacheco3, Manuel Menendez-Gonzalez4, Rafael C Freire5, Sergio Machado5, Eric Murillo-Rodriguez6, Antonio E Nardi5, Oscar Arias-Carrion7.   

Abstract

BACKGROUND &
OBJECTIVE: Epilepsy is one of the most complex neurological disorders and its study requires a broad knowledge of neurology and neuroscience. It comprises a diverse group of neurological disorders that share the central feature of spontaneous recurrent seizures, and are often accompanied by cognitive deficits and mood disorder. This condition is one of the most common neurological disorders. Until recently, alterations of neuronal activities had been the focus of epilepsy research. This neurocentric emphasis did not address issues that arise in more complex models of epileptogenesis. An important factor in epilepsy that is not regulated directly by neurons is inflammation and the immune response of the brain. Recent evidence obtained in rodent epilepsy models supports the role of immune responses in the initiation and maintenance of epilepsy. Recognition of exogenous pathogens by the innate immune system is mediated by some pattern recognition receptors such as Toll-like receptors leading to cell activation and cytokine production. Currently, these receptors have been the focus of epilepsy studies looking to determine whether the innate immune activation is neuroprotective or neurotoxic for the brain.
CONCLUSION: Here, we present the evidence in the literature of the involvement of key innate immune receptors in the development of epilepsy. We address some of the contradictory findings in these studies and also mention possible avenues for research into epilepsy treatments that target these receptors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cytokines; epilepsy; epileptogenesis; innate immune system; neurological; toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28745241     DOI: 10.2174/1871527316666170725145549

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  2 in total

1.  Expression Analysis of lncRNAs in Refractory and Non-Refractory Epileptic Patients.

Authors:  Sara Mirzajani; Soudeh Ghafouri-Fard; Jafar Mehvari Habibabadi; Shahram Arsang-Jang; Mir Davood Omrani; Seyed Sohrab Hashemi Fesharaki; Arezou Sayad; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2020-01-03       Impact factor: 3.444

2.  Expression Profile of Immunoglobulin G Glycosylation in Children With Epilepsy in Han Nationality.

Authors:  Yuejin Li; Fengxue Shi; Guanglei Wang; Jian Lv; Haitao Zhang; Hao Jin; Xueyu Chen; Meng Wang; Peirui Li; Long Ji
Journal:  Front Mol Neurosci       Date:  2022-07-01       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.